Does RISANKIZUMAB-RZAA Cause Blindness unilateral? 52 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Blindness unilateral have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
52
Reports of Blindness unilateral with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Blindness unilateral From RISANKIZUMAB-RZAA?
Of the 52 reports, 6 (11.5%) required hospitalization.
Is Blindness unilateral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Blindness unilateral?
AFLIBERCEPT (1,012)
ADALIMUMAB (831)
INSULIN GLARGINE (285)
INTERFERON BETA-1A (275)
RANIBIZUMAB (274)
DIMETHYL (272)
INSULIN LISPRO (267)
TOCILIZUMAB (215)
NATALIZUMAB (168)
BEVACIZUMAB (165)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Blindness unilateral Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA